Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
Tag: catalyst
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals
Recently, we have detailed companies that have released positive Phase III data because we believe several of these companies continue to be under speculation value. Companies who have strong management, cash, and a strong pipeline can be very profitable for…
Corrected Video: Market Commentary + Trade Watch Update 7/13/13
Some commentary from me on recent market action plus chart commentary on some of our recent picks. $GTXI $TSRX $SGMO $DRRX $SGMO $FB $BBY
4 Biopharmas On Catalyst Watch List For Week 7/8/2013
Stockmatusow.com has compiled 4 biopharmas with significant near-term catalysts ahead that should drive their respective stock prices higher. We think each of these companies should also be looked at for speculation investments. Since the companies listed below are smaller caps,…
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called aerobic respiration, which generates a usable form of energy. Glycolysis is the beginning…
Chart Update For June 17-21
Chart Update For June 17-21. $MNKD $BIOD $TSRX $GTXI
Wednesday’s Biotech Catalyst Trade Watch List
Today, I list four biotech companies with significant near-term catalysts ahead. Under normal market conditions, these stocks should see decent to very strong appreciation in the short-term. There are various ways to play these catalyst trades. Traders and investors can…
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
These days, prescription drugs have become a source for legal and illegal abuse. This abuse can lead to a medical diagnosis called opioid dependence, which is when a patient that is addicted to opioids such as morphine, hydrocodone, oxycodone, or…
Biosciences Delivery Systems+ Antares Chart Update: 5/25/13 $BDSI, $ATRS
My opinion on Antares BDSI pasy trading action and for the future.
I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.
BioDelivery Sciences (BDSI) focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. …